Effect of AKB-6548 on the Pharmacokinetics of Celecoxib

NCT02502500 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Celecoxib
DRUG: AKB-6548

Sponsor

Akebia Therapeutics